ID   ICAL_RAT                Reviewed;         713 AA.
AC   P27321; A5GXY4; A5GXY5; A5GXY6; A5GXY7; A5GXY8; A5GXY9; A5GXZ7; O55151;
AC   O55152; O55153; Q5BK19; Q99MG1; Q99MG2;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 3.
DT   02-OCT-2024, entry version 152.
DE   RecName: Full=Calpastatin;
DE   AltName: Full=Calpain inhibitor;
GN   Name=Cast;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6 AND 7).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=17570336; DOI=10.1016/j.abb.2007.05.007;
RA   De Tullio R., Averna M., Stifanese R., Parr T., Bardsley R.G.,
RA   Pontremoli S., Melloni E.;
RT   "Multiple rat brain calpastatin forms are produced by distinct starting
RT   points and alternative splicing of the N-terminal exons.";
RL   Arch. Biochem. Biophys. 465:148-156(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 55-713 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2015306; DOI=10.1016/0167-4781(91)90139-d;
RA   Ishida S., Emori Y., Suzuki K.;
RT   "Rat calpastatin has diverged primary sequence from other mammalian
RT   calpastatins but retains functionally important sequences.";
RL   Biochim. Biophys. Acta 1088:436-438(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 55-713 (ISOFORMS 1; 2 AND 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9475181; DOI=10.1016/s0014-5793(97)01588-3;
RA   De Tullio R., Sparatore B., Salamino F., Melloni E., Pontremoli S.;
RT   "Rat brain contains multiple mRNAs for calpastatin.";
RL   FEBS Lett. 422:113-117(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 59-713 (ISOFORMS 1 AND 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RA   Risbood M.P., Lin H., Lee T.;
RT   "Hypoxic induction of two rat cardiac calpastatin cDNAs.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 60-188 (ISOFORMS 1; 2 AND 4).
RC   STRAIN=Fischer;
RX   PubMed=1730065; DOI=10.1016/0167-4781(92)90500-y;
RA   Lee W.J., Hatanaka M., Maki M.;
RT   "Multiple forms of rat calpastatin cDNA in the coding region of
RT   functionally unknown amino-terminal domain.";
RL   Biochim. Biophys. Acta 1129:251-253(1992).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-122; SER-171;
RP   THR-173; SER-260; SER-580 AND SER-582, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 193-278 IN COMPLEX WITH CAPN2 AND
RP   CAPNS1.
RX   PubMed=19020622; DOI=10.1038/nature07353;
RA   Moldoveanu T., Gehring K., Green D.R.;
RT   "Concerted multi-pronged attack by calpastatin to occlude the catalytic
RT   cleft of heterodimeric calpains.";
RL   Nature 456:404-408(2008).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 571-664 IN COMPLEX WITH CAPN2 AND
RP   CAPNS1, INHIBITORY DOMAINS, AND MUTAGENESIS OF GLY-613.
RX   PubMed=19020623; DOI=10.1038/nature07451;
RA   Hanna R.A., Campbell R.L., Davies P.L.;
RT   "Calcium-bound structure of calpain and its mechanism of inhibition by
RT   calpastatin.";
RL   Nature 456:409-412(2008).
CC   -!- FUNCTION: Specific inhibition of calpain (calcium-dependent cysteine
CC       protease). Plays a key role in postmortem tenderization of meat and
CC       have been proposed to be involved in muscle protein degradation in
CC       living tissue.
CC   -!- INTERACTION:
CC       P27321; Q07009: Capn2; NbExp=10; IntAct=EBI-7441624, EBI-1040438;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=A;
CC         IsoId=P27321-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P27321-2; Sequence=VSP_000754;
CC       Name=3; Synonyms=C;
CC         IsoId=P27321-3; Sequence=VSP_026972;
CC       Name=4;
CC         IsoId=P27321-4; Sequence=VSP_000753, VSP_000754;
CC       Name=5;
CC         IsoId=P27321-5; Sequence=VSP_000754, VSP_026972;
CC       Name=6;
CC         IsoId=P27321-6; Sequence=VSP_000753, VSP_000754, VSP_026972;
CC       Name=7;
CC         IsoId=P27321-7; Sequence=VSP_026971;
CC   -!- DOMAIN: Each of the four flexible inhibitory domains can inhibit one
CC       calcium-bound calpain molecule by occupying both sides of the active
CC       site.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I27 (calpastatin) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK29411.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAK29412.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA40053.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA40053.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA73915.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA73916.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA73917.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ186624; ABA86879.1; -; mRNA.
DR   EMBL; DQ186625; ABA86880.1; -; mRNA.
DR   EMBL; DQ186626; ABA86881.1; -; mRNA.
DR   EMBL; DQ186627; ABA86882.1; -; mRNA.
DR   EMBL; DQ186628; ABA86883.1; -; mRNA.
DR   EMBL; DQ186629; ABA86884.1; -; mRNA.
DR   EMBL; DQ287975; ABB90254.1; -; mRNA.
DR   EMBL; BC091239; AAH91239.1; -; mRNA.
DR   EMBL; X56729; CAA40053.1; ALT_SEQ; mRNA.
DR   EMBL; Y13587; CAA73915.1; ALT_INIT; mRNA.
DR   EMBL; Y13588; CAA73916.1; ALT_INIT; mRNA.
DR   EMBL; Y13589; CAA73917.1; ALT_INIT; mRNA.
DR   EMBL; AF346597; AAK29411.1; ALT_INIT; mRNA.
DR   EMBL; AF346598; AAK29412.1; ALT_INIT; mRNA.
DR   EMBL; X62520; CAA44386.1; -; mRNA.
DR   PIR; S15074; S15074.
DR   PIR; S20611; S20611.
DR   RefSeq; NP_001028887.1; NM_001033715.1.
DR   RefSeq; NP_001028888.1; NM_001033716.1.
DR   RefSeq; NP_445747.2; NM_053295.2.
DR   PDB; 3BOW; X-ray; 2.40 A; C=571-664.
DR   PDB; 3DF0; X-ray; 2.95 A; C=193-278.
DR   PDBsum; 3BOW; -.
DR   PDBsum; 3DF0; -.
DR   AlphaFoldDB; P27321; -.
DR   SMR; P27321; -.
DR   DIP; DIP-44338N; -.
DR   IntAct; P27321; 1.
DR   MINT; P27321; -.
DR   STRING; 10116.ENSRNOP00000058759; -.
DR   MEROPS; I27.001; -.
DR   MEROPS; I27.002; -.
DR   MEROPS; I27.003; -.
DR   iPTMnet; P27321; -.
DR   PhosphoSitePlus; P27321; -.
DR   jPOST; P27321; -.
DR   PaxDb; 10116-ENSRNOP00000058759; -.
DR   PeptideAtlas; P27321; -.
DR   GeneID; 25403; -.
DR   KEGG; rno:25403; -.
DR   AGR; RGD:2278; -.
DR   CTD; 831; -.
DR   RGD; 2278; Cast.
DR   eggNOG; ENOG502RHIZ; Eukaryota.
DR   InParanoid; P27321; -.
DR   OrthoDB; 5359611at2759; -.
DR   PhylomeDB; P27321; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   EvolutionaryTrace; P27321; -.
DR   PRO; PR:P27321; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ARUK-UCL.
DR   GO; GO:0010859; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; IDA:RGD.
DR   GO; GO:0002020; F:protease binding; IDA:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0007343; P:egg activation; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; IEP:RGD.
DR   GO; GO:0007520; P:myoblast fusion; IEP:RGD.
DR   GO; GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; ISO:RGD.
DR   GO; GO:0042176; P:regulation of protein catabolic process; TAS:RGD.
DR   GO; GO:0014732; P:skeletal muscle atrophy; IEP:RGD.
DR   DisProt; DP01994; -.
DR   InterPro; IPR026998; Calpastatin.
DR   InterPro; IPR001259; Prot_inh_calpain.
DR   PANTHER; PTHR10077; CALPASTATIN; 1.
DR   PANTHER; PTHR10077:SF0; CALPASTATIN; 1.
DR   Pfam; PF00748; Calpain_inhib; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Isopeptide bond;
KW   Phosphoprotein; Protease inhibitor; Reference proteome; Repeat;
KW   Thiol protease inhibitor; Ubl conjugation.
FT   CHAIN           1..713
FT                   /note="Calpastatin"
FT                   /id="PRO_0000147635"
FT   REPEAT          208..260
FT                   /note="Inhibitory domain 1"
FT   REPEAT          341..393
FT                   /note="Inhibitory domain 2"
FT   REPEAT          451..504
FT                   /note="Inhibitory domain 3"
FT   REPEAT          588..641
FT                   /note="Inhibitory domain 4"
FT   REGION          1..152
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          253..402
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          442..507
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          544..713
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        47..77
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        78..100
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        107..136
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        327..346
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        347..401
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        442..502
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        563..652
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        673..713
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51125"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         173
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         401
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         532
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        69
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P20810"
FT   VAR_SEQ         1..177
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17570336"
FT                   /id="VSP_026971"
FT   VAR_SEQ         67..79
FT                   /note="Missing (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:1730065,
FT                   ECO:0000303|PubMed:17570336"
FT                   /id="VSP_000753"
FT   VAR_SEQ         98..135
FT                   /note="Missing (in isoform 2, isoform 4, isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:1730065, ECO:0000303|PubMed:17570336,
FT                   ECO:0000303|PubMed:9475181, ECO:0000303|Ref.5"
FT                   /id="VSP_000754"
FT   VAR_SEQ         166..188
FT                   /note="Missing (in isoform 3, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17570336,
FT                   ECO:0000303|PubMed:9475181, ECO:0000303|Ref.5"
FT                   /id="VSP_026972"
FT   MUTAGEN         613
FT                   /note="G->A: 2.9-fold increase in the IC(50)."
FT                   /evidence="ECO:0000269|PubMed:19020623"
FT   MUTAGEN         613
FT                   /note="G->FG: Turns CAST from an inhibitor into a
FT                   substrate."
FT                   /evidence="ECO:0000269|PubMed:19020623"
FT   CONFLICT        161
FT                   /note="K -> E (in Ref. 1; CAA40053 and 5; AAK29411)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209
FT                   /note="N -> S (in Ref. 4; CAA73917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        314
FT                   /note="K -> E (in Ref. 5; AAK29412)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        463
FT                   /note="V -> G (in Ref. 1; ABA86879/ABA86880/ABA86881/
FT                   ABA86882/ABA86883/ABA86884/ABB90254 and 4; CAA73916)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        481
FT                   /note="T -> A (in Ref. 4; CAA73917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="D -> G (in Ref. 4; CAA73917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        611
FT                   /note="K -> R (in Ref. 4; CAA73915)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        646
FT                   /note="L -> P (in Ref. 2; AAH91239, 4; CAA73915/CAA73917
FT                   and 5; AAK29411/AAK29412)"
FT                   /evidence="ECO:0000305"
FT   HELIX           195..199
FT                   /evidence="ECO:0007829|PDB:3DF0"
FT   HELIX           236..238
FT                   /evidence="ECO:0007829|PDB:3DF0"
FT   HELIX           241..247
FT                   /evidence="ECO:0007829|PDB:3DF0"
FT   HELIX           271..274
FT                   /evidence="ECO:0007829|PDB:3DF0"
FT   TURN            275..277
FT                   /evidence="ECO:0007829|PDB:3DF0"
FT   HELIX           573..581
FT                   /evidence="ECO:0007829|PDB:3BOW"
FT   HELIX           616..618
FT                   /evidence="ECO:0007829|PDB:3BOW"
FT   HELIX           621..627
FT                   /evidence="ECO:0007829|PDB:3BOW"
FT   HELIX           652..659
FT                   /evidence="ECO:0007829|PDB:3BOW"
SQ   SEQUENCE   713 AA;  77313 MW;  55505300F59A8DE3 CRC64;
     MSRPGPKPAA SSRPRRGAAA SHTQEHVNEK NIGSSSKPAE KKGSDEVTAS SAATGTSPRM
     STTGAKAVKI ESEKSQSSEP PVIHEKKPKG KPKEGSEPQT LPKHASDTGS KHAHKEKALS
     RSNEQIVSEK SSESKTKFQD APSADGESVA GGVTVATASD KVVVKKKEKK SLTPTLPMES
     TLNKLSDKSG VNAALDDLID TLGECEDTNK DDPPYTGPVV LDPMDSTYLE ALGIKEGTIP
     PEYRKLLEKN EAITGPLPDS PKPMGIDHAI DALSSDFTCS SPTGKQTEKE KSTGESSKAQ
     SAGVTRSAVP PQEKKRKVEE EVMNDQALQA LSDSLGTRQP DPQSHLRQAK QVKEAKAKEE
     RQEKCGEDED TVPAEYRLKP AKDKDGKPLL PEPEETSKCL SESELIGELS ADFVQPTYQE
     KPSMPAAKIK KGVVPDDAVE TLARSLGTRK EDPEDEKSLV DKVKEKAKEE DHEKLGEKEE
     TIPPDYRLEI VKDKDGKPLL PKEAEEQLPP LSDDFLLDAL SQDFSSPANI LSLGFEDAKL
     SAAVSETVSQ VPAPSNHTAA PPPGTERRDK ELDDALDELS DSLGQRQPDP DENKPLDDKV
     KEKIKAEHSE KLGERDDTIP PEYRHLLDND GKDKPEKPLT KNTEKLGQDQ DPIDALSEDL
     DSCPPTTETS QNTTKEKGKK TSSSKASKNE EKTKDSSKKT EEVPKPKVDE DAT
//
